1/104
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
antimicrobial (anti-infective)
work on many different organisms
bacteria, viruses, fungal, protozoa, helminths
natural, synthetic, semi-synthetic
antibiotic
subcategory of antimicrobial that can kill or inhibit growth of bacteria
two types of antibiotics
bacteriostatic, bactericidal
bacteriostatic
meds that slow or inhibit bacterial growth
bactericidal
meds that kill bacteria
broad spectrum
often used first when don’t know what bacteria is
effective against many organisms, both gram + and gram -
don’t know what specific organism is
narrow spectrum
effective against few species of organisms, usually gram + OR gram -
know organism and sensitivity of pattern
selective toxicity
toxic to specific cells while sparing other cells in close proximity
resistance
ability of organism to survive against and antimicrobial or render it ineffective
innate or acquired
if gram - bacteria, gram + med won’t work
super infection
occurs because of/during treatment of a primary infection
second infection superimposed on an earlier infection
different microbe
resistant microbe
ex. C. diff
prophylactic antibiotic use
prevent infection from occuring
when high risk of infection
surgical procedures: orthopedic, cardiac, abdominal
dental procedures in pts at risk for endocarditis
prosthetic valve, hip/knee replacement
immunocompromised
neutropenia: HIV, chemo, immunosuppression
opportunistic infection
ex. C-diff
organism takes advantage of opp. that usually isn’t there
weakened immune system, altered microbiome, breached integumentary barriers
organisms cause no infection in healthy host
some organisms live as commensals
symbiotic relatinship
in order to cause infection, and organism must…
get by body’s defense mechanisms
innate immunity
all defenses we possess to prevent in organism from invading the body
adaptive immunity
ability to recognize organisms and attack with specialized cells
can be gained via vaccines
organism entry areas
oro/nasopharynx: bronchial airways, lungs, stomach, GIT
disruption in barrier (skin)
genitourinary tract
how organisms enter the body
move from non-sterile site to sterile site
translocation
movement of bacteria across the intestinal lining
into peritoneal cavity
into blood
blood-blood transfusion
blood transfusions, needle stick
maternal-fetal transmission
cross placental barrier and directly infect the baby
during birth
stages of infection
incubation, prodromal, acute, decline, convalescent, resolution
incubation
time from exposure to onset of symptoms
prodromal
after incubation and before ‘characteristic’ symptoms occur
acute
clinical disease symptoms apparent
decline
immune system responds and symptoms gradually improve
convalescent
symptoms resolve and person can return to normal function
resolution
gone
infectious process: injury
injury
short period of vasoconstriction
helps stop bleeding and prevent invading organisms moving beyond injury site
then prolonged vasodilation
increased blood flow to area, bring immune cells to area
contributes to inflammation symptoms
infectious process: increased permeability
fluid pushed out of vascular space
fluid moves to exact area of injury
WBCs get to infection area
causes edema and swelling
infectious process: emigration of leukocytes
neutrophils attracted to area (most abundant WBC)
attracted to area of injury
attach to endothelium and move into surrounding tissues
emigration or diapedesis
eosinphils, NK cells, monocytes
infectious process: phagocytosis
neutrophils and monocytes enter area of injury
recognize, engulf, then destroy the organisms
infectious process: exudate
fluid that leaks out of blood vessels
cells and debris from phagocytosis
transport leukocytes + antibodies to area
dilutes toxins that may be present
transports nutrients for healing process
types of exudate
serous
fibrinous
purulent
hemorrhagic
infectious process: systemic symptoms
if the process does not remain localized
total body response r/t release of mediators
stimulation of the hypothalamic fever set point
pro-inflammatory mediators: interleukins (IL) and tumor necrosis factor (TNF-alpha)
interleukins (IL) and tumor necrosis factor (TNF-alpha)
fever set point increases, body conserves heat
defense mech to rid body of organisms, some bacteria less virulent and divide slower
improves the immune system
better neutrophil and macrophage function
improved antibody release and T cell activation
nosocomial infections
infections that occur within a healthcare facility
drug resistant strains in HAIs
resistance to specific drug
MRSA
resistance to an antimicrobial class
CRE
resistance to multiple drugs/classes (MDRO, MDR)
post-op infections
resp - atelectasis, increased risk of pneumonia
surgical wound infections - wound dehiscence, opening of wound - bacteria
UTIS
how antimicrobial is chosen
community vs hospital acquired
site of infection
suspected organism
always get cultures before starting antimicrobials unless…
suspiciion of meningitis or severe sepsis
minimum inhibitory concentration (MIC)
grow organisms in tubes that have diff concentrations of an antimicrobial
min. inhibitory concentration
lowest concentration that decreases size of colonies by 99.9% (lowest that kills organism)
trough levels
time between doses, is drug being excreted properly?
peak levels
blood level needs to have enough concentration to be effective
superinfections
new infection that occurs during treatment for a diff infection
may be caused by resistant organisms
antimicrobials also inhibit or kill normal, helpful flora (GIT, skin)
C-diff
normal intestinal flora are killed by antimicrobial administration
C-diff can grow w/o control factor
diarrhea, stool for C.diff toxin, don’t send for culture
never give antidiarrheal until sure diarrhea not caused by infection
pseudomembranous colitis
caused by antidiarrheal when diarrhea caused by infection
life threatening
dilation of colon
candidiasis
antimicrobial agents kill normal flora, overgrowth of fungus
oral and may extend into esophagus, vaginal
mycostatin, nystatin
antimicrobial resistance
organisms grow where antimicrobials present
innate resistance
mutation from exposure to antimicrobial agent, not give or taken long enough to kill all organisms
beta-lactamase
enzyme produced by bacteria that cleaves beta lactam ring off antibiotic, making resistant to antibiotics with this ring
gram + organisms export enzymes into surrounding area
gram - organisms produce small amts b/t cell wall and cytoplasmic membrane
aztreonam
has beta lactam ring that is not attached to anything else, so not affected by B-lactamase
markers of resistance
MecA gene
tested for in lab to identify organisms, esp. MRSA
beta-lactamase inhibitors
resemble b-lactam structure
bind to b-lactamase and protect antibiotic from destruction
beta-lactamase inhibitors
tazobectam: piperacillin - Zosyn
avibactam: ceftazidime - Avycaz
MDROs ESKAPE
• E Enterococcus faecium
• S Staphylococcus aureus
• K Klebsiella pneumoniae
• A Acinetobacter baumannii
• P Pseudomonas aeruginosa
• E Enterobacter spp
polymixin
bactericidal for most Gm - aerobic rods
poor tissue distribution
substantial toxicity
systemic use only multi-drug-resistant bacteria
antimicrobials MOAs
• Inhibit cell wall synthesis - bacteriacidal
• Increase cell wall permeability - bactericidal
• Inhibition of protein synthesis - bactericidal or bacteriostatic
• Lethal
• Non-lethal
• Inhibition of DNA/RNA synthesis / alter the function
• Disrupt specific metabolic or biochemical reactions
• Suppress replication of viruses
• Multiple steps
antimicrobials categories
increase activity against another class of organisms (increase gr - activity for drug og only effective against gr+ organisms)
improve accessibility
counteract resistance (B-lactamase)
action against cell wall
bactericidal
weaken cell wall
higher concentration of stuff inside cell
influx of fluid into cell - burst
spills cell contents which causes increased inflammation
cell lysis and then death
gram + parts
cell wall
gram - parts
outer membrane, cell wall, cytoplasmic membrane
antibiotics that effect the cell wall
penicillins
cephalosporins
carbapenems
vancomycin
aztreonam
teicoplanin
fosfomycin
penicillin activity and toxicity
broad activity
low toxicity - may be anaphylactic allergy
Mammalian cells do not have a cell wall
penicillin MOA
works on active infections
penicillin binding protein
increase protein synthesis
increase other cellular processes
autolysis activation
penicillin category 1: narrow spectrum, penicillinase sensitive
PCN G - unstable in gastric acid, no oral
PCN. V - oral, stable in acid
penicillin category 2: narrow spectrum, penicillinase resistant
eathicillin + oxacillin (MRSA), nafcillin, dicloxacillin
penicillin category 3: broad spectrum, amino-penicillins
ampicillin, amoxicillin
penicillin category 4: extended spectrum- anti-pseudonomal
ticarcillin, piperacillin
where is penicillin metabolized? eliminated?
liver, kidneys
piperacillin-tazobactam
excreted (mostly unchanged) by kidney
only given IV
can disrupt platelet function
may see bleeding, but no platelet count change
gram - organisms
dose adjusted in renal insufficiency
cephalosporin similarities to penicillin
bind to PCP
disrupt cell wall synthesis (bactericidal)
activate autolysis (bacteria self-destroy)
cephalosporin toxicity
low tox, but cross-sensitivity to penicillin
avoid with anaphylactic penicillin reaction
most common reaction is rash
cephalosporin 1st gen
cephalexin, cefazolin
gram +
cephalosporin 2nd gen
cefotetan
cefuroxime + cefoxitin can be given IV, esp. when shortage of IV fluids!!
cephalosprin 3rd gen
ceftazidime (B. lact. inhibitor)
ceftriaxone
IV push
1st line treatment for bacterial meningitis
treatment for gonorrhea infection
cephalosporin 4th gen
cefepime
can rapidly penetrate outer membrane
can be used on gram -
how is cephalosporin absorbed? eliminated?
poor oral absorption
most eliminated by kidneys (don’t get peak and trough)
usually given IV
carbapenems
very broad coverage
thought of as last resort
CROs
most common is meropenem
imipenem
1st one
combined with cilastin to stop destruction by kidney enzymes
can induce seizure activity
meropenem
broad coverage
no degradation by kidney enzymes
less seizure activity
vancomycin basics
own class of med
commonly used with pt coming in with infection in case of MRSA
no b. lactam ring
inhibits cell wall synthesis
glycopeptide antibiotic
no oral absorption
vancomycin which type of gram
serious gram + infections
wide distribution
vancomycin elimination and toxicity
eliminated by kidneys (peak and trough levels)
toxic - immune-mediated thrombocytopenia (decreased platelet count and increased bleeding risk)
vancomycin infusion-related reaction
rapid infusion
flusing, rash, pruritis, urticaria, tachycardia, hypotension
must infuse slowly, at least greater than 60 min
daptomycin
cyclic lipopeptide
disrupt cell membrane
bactericidal against gram + bacteria only
can be used with MRSA when resistant to vancomycin
interact with pulmonary surfactant that inhibits antibacterial (can’t use on someone with lung infection)
aztreonam
monobactam class
B-lactam ring not fused to another ring (resistant to B-lact.)
only works on gram - bacteria (resistant to B-lact. producing gram - organisms)
only IV
aztreonam elimination and adverse effects
eliminated by kidneys
thrombophlebitis
slight risk of cross-allergy to pcn or cephalosporins
intracellular activity drugs
aminoglycosides
lincosamides
macrolides
oxazolindinones
streptogramins
tetracyclines
glycylcycline
fluoroquinolones
cycliclipopeptides
sulfonamides
metronidazole
aminoglycosides
good against gram - bacteria
staphylococci coverage
severe reactions: ototoxicity (ears), nephrotoxicity
gentamycin (prototype)
aminoglycoside
transported across cell membrane
requires o2 (aerobic)
given IV
concentration 50x higher in kidney than in the serum (and concentrated in inner ear)
must get into cell to work
peak and trough levels (with IV dosing)
gentamycin adverse effects
ototoxicity - balance
nephrotoxicity - acute tubular necrosis
neuromuscular blockade - myasthenia gravis - resp. weakness
confusion, depression, disorientation, numbness, tingling
amikacin, kanamycin, neomycin
amikacin - broad spectrum, less resistance
neomycin - topical, highest toxicity (don’t give IV)
tobramycin, streptomycin
tobramycin
better coverage of psuedonomas
inhalation - resp. infections, cystic fibrosis
streptomycin
TB treatment
plaque
tularemia - infection from rabbits
clindamycin
lincosamides
-cidal or -static depending on dose
very toxic
broad coverage (aerobic g + or anaerobic g+ or g-)
prophylaxis prior to dental procedures
ppl with hip, knee, or valve replacement
clindamycin adverse effects
risk of C.diff (huge for long-term)
pseudomembranous colitis
dryness of skin and conjuctiva
erythromycin
macrolides
may be -cidal
legionnarie’s disease
mycoplasma pneumoniae
diptheria
used to be used for chlamydial infections
erythromycin benefits
hypomotility
diabetic gastroparesis
increase gastric motility and emptying
azithromycin
long ½ life (daily dosing)
doesn’t interfere with human protein synthesis (better tolerated)
absorption
capsule - take on empty stomach (decreased with food)
suspension - increased with food
linezolid
oxazolidinones
specifically developed for MRSA (with resistance to vancomycin)
oral and PN
AE: rash, fever, diarrhea, headache, n/v
oral suspension contains phenylaline - use with caution for: MAOIs, HTN
phenylalanine
can increase tyramine in the body
increased level can lead to high BP
caution with MAOIs - can lead to dangerously high BP
tetracycline
broad spectrum, major resistance has developed
used for lyme disease, cholera, rocky mountain spotted fever
AE: n/v/d, headache, photosensitivity, dizzines, rare anaphylaxis
concentrate sin bone, liver, tumor, spleen, and esp. teeth
causes damage to teeth if less than 8 years or all permanent teeth not in place